HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia.

Abstract
Epigenetic dysregulation is an emerging hallmark of cancers. We developed a high-information-content mass spectrometry approach to profile global histone modifications in human cancers. When applied to 115 lines from the Cancer Cell Line Encyclopedia, this approach identified distinct molecular chromatin signatures. One signature was characterized by increased histone 3 lysine 36 (H3K36) dimethylation, exhibited by several lines harboring translocations in NSD2, which encodes a methyltransferase. A previously unknown NSD2 p.Glu1099Lys (p.E1099K) variant was identified in nontranslocated acute lymphoblastic leukemia (ALL) cell lines sharing this signature. Ectopic expression of the variant induced a chromatin signature characteristic of NSD2 hyperactivation and promoted transformation. NSD2 knockdown selectively inhibited the proliferation of NSD2-mutant lines and impaired the in vivo growth of an NSD2-mutant ALL xenograft. Sequencing analysis of >1,000 pediatric cancer genomes identified the NSD2 p.E1099K alteration in 14% of t(12;21) ETV6-RUNX1-containing ALLs. These findings identify NSD2 as a potential therapeutic target for pediatric ALL and provide a general framework for the functional annotation of cancer epigenomes.
AuthorsJacob D Jaffe, Yan Wang, Ho Man Chan, Jinghui Zhang, Robert Huether, Gregory V Kryukov, Hyo-eun C Bhang, Jordan E Taylor, Min Hu, Nathan P Englund, Feng Yan, Zhaofu Wang, E Robert McDonald 3rd, Lei Wei, Jing Ma, John Easton, Zhengtian Yu, Rosalie deBeaumount, Veronica Gibaja, Kavitha Venkatesan, Robert Schlegel, William R Sellers, Nicholas Keen, Jun Liu, Giordano Caponigro, Jordi Barretina, Vesselina G Cooke, Charles Mullighan, Steven A Carr, James R Downing, Levi A Garraway, Frank Stegmeier
JournalNature genetics (Nat Genet) Vol. 45 Issue 11 Pg. 1386-91 (Nov 2013) ISSN: 1546-1718 [Electronic] United States
PMID24076604 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Chromatin
  • Histones
  • Repressor Proteins
  • Histone-Lysine N-Methyltransferase
  • NSD2 protein, human
Topics
  • Animals
  • Base Sequence
  • Cell Line, Tumor
  • Child
  • Chromatin (genetics)
  • Female
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Histone-Lysine N-Methyltransferase (genetics)
  • Histones (genetics)
  • Humans
  • Mice
  • Mice, SCID
  • NIH 3T3 Cells
  • Neoplasm Transplantation
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (genetics)
  • Repressor Proteins (genetics)
  • Sequence Analysis, DNA
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: